Penny Towne
Impact in
-
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 5
- Peptidase Inhibition and Analysis 1
- Pancreatic and Hepatic Oncology Research 1
- Cancer Cells and Metastasis 1
- Cancer Immunotherapy and Biomarkers 1
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Shalini Singh (2 shared papers)Steffan N. Ho (2 shared papers)Abigail McElhinny (4 shared papers)J. Burns Amberson (1 shared paper)Zoran Gatalica (1 shared paper)Isabell R. Loftin (2 shared papers)Jim Ranger‐Moore (2 shared papers)Hiroaki Nitta (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Thoracic Oncology (2 papers)Antibodies (1 paper)Journal of Cellular Biochemistry (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Penny Towne
8 papers receiving 90 citations
Peers
Comparison fields: 5 of 18
- Oncology 46
- Pulmonary and Respiratory Medicine 50
- Cancer Research 18
- Biotechnology 4
- Biophysics 2
Countries citing papers authored by Penny Towne
This map shows the geographic impact of Penny Towne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penny Towne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penny Towne more than expected).
Fields of papers citing papers by Penny Towne
This network shows the impact of papers produced by Penny Towne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penny Towne. The network helps show where Penny Towne may publish in the future.
Co-authors
The 25 scholars most cited alongside Penny Towne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 38 | |
| 2 | 2013 | 24 | |
| 3 | 2021 | 12 | |
| 4 | 2020 | 6 | |
| 5 | 2022 | 4 | |
| 6 | 2016 | 3 | |
| 7 | 2012 | 2 | |
| 8 | 2019 | 1 | |
| 9 | 2025 | 0 |
About Penny Towne
Penny Towne is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Genetics, having authored 9 papers that have together received 90 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Peptidase Inhibition and Analysis (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Cancer Cells and Metastasis (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Microfluidic and Capillary Electrophoresis Applications (1 paper). The work is most often cited by research in Oncology (46 citations), Pulmonary and Respiratory Medicine (50 citations), Cancer Research (18 citations), Biotechnology (4 citations) and Biophysics (2 citations). Penny Towne has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Shalini Singh, Steffan N. Ho, Abigail McElhinny, J. Burns Amberson, Zoran Gatalica, Isabell R. Loftin, Jim Ranger‐Moore, Hiroaki Nitta, Brian Kelly and Katie White. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Antibodies, Journal of Cellular Biochemistry and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.